Spain-based SOM Biotech is a drug discovery company that uses artificial intelligence to find new medical uses for existing drugs. This approach, known as drug repurposing, can make drug development faster, cheaper, and less risky because these medicines often already have safety and clinical data available. SOM focuses especially on rare diseases, where patients often have limited treatment options, and its AI platform helps identify promising drug candidates that can be moved into clinical testing more efficiently than developing a completely new medicine from scratch.